Value of drug-eluting stents in cardiac transplant recipients.
暂无分享,去创建一个
A. Kirtane | J. Moses | M. Leon | D. Mancini | C. Marboe | L. Rabbani | S. Kodali | Anuj Gupta | Ryan K Kaple | Ryan K. Kaple | M. Apfelbaum
[1] H. Ly,et al. In-stent restenosis and remote coronary lesion progression are coupled in cardiac transplant vasculopathy but not in native coronary artery disease. , 2006, Journal of the American College of Cardiology.
[2] Shawn A. Gregory,et al. Comparison of sixty-four-slice multidetector computed tomographic coronary angiography to coronary angiography with intravascular ultrasound for the detection of transplant vasculopathy. , 2006, The American journal of cardiology.
[3] R. Wilson,et al. Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients. , 1995, Journal of the American College of Cardiology.
[4] D. Mancini,et al. Anti-Human Leukocyte Antigen Antibodies are Associated with Restenosis after Percutaneous Coronary Intervention for Cardiac Allograft Vasculopathy , 2005, Transplantation.
[5] Marshall I Hertz,et al. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heart-lung transplantation report--2006. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[6] M. Mehra,et al. Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation. , 2004, The American journal of cardiology.
[7] A. Yeung,et al. Changes in coronary anatomy and physiology after heart transplantation. , 2007, The American journal of cardiology.
[8] J. Tobis,et al. Usefulness and safety of percutaneous coronary interventions for cardiac transplant vasculopathy. , 2006, The American journal of cardiology.
[9] P. Macdonald,et al. Sirolimus in De Novo Heart Transplant Recipients Reduces Acute Rejection and Prevents Coronary Artery Disease at 2 Years: A Randomized Clinical Trial , 2004, Circulation.
[10] E. Tuzcu,et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. , 2003, The New England journal of medicine.
[11] D. Renlund,et al. Percutaneous coronary interventions with stents in cardiac transplant recipients. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.